NASDAQ$WWD

Woodward Inc. · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

Woodward's first quarter of fiscal year 2021 showed signs of stabilization in its markets, but the impact of COVID-19 remained an ever-present risk.

Woodward reported a decrease in net sales by 25 percent, with net sales of $538 million. Net earnings were $42 million, or $0.64 per share, compared to $53 million, or $0.83 per share, for the first quarter of fiscal 2020.

  • Net sales for the first quarter of fiscal 2021 were $538 million, a decrease of 25 percent compared to the first quarter of last year.
  • Net earnings were $42 million, or $0.64 per share, for the first quarter of 2021.
  • Aerospace segment net sales decreased by 32 percent to $322 million due to the impact of COVID-19 on passenger travel.
  • Industrial segment net sales decreased by 12 percent to $216 million, primarily due to the divestiture of RPS, a weak oil and gas market and the continued impact of the pandemic.

Headline financials

Total Revenue

$538M

Previous: $720M-25.4%
EPS (adj)

$0.64

Previous: $1.10-41.8%
Effective tax rate

12.6%

Previous: 13.3%-5.3%
Capital Expenditures

-$7.26M

Previous: -$17.2M+57.9%
Free Cash Flow

$34.3M

Previous: $36.1M-5.1%
Net Income

$41.6M

Previous: $53.4M-22.1%
Operating Income

-$536M

Previous: -$667M+19.6%
Gross Profit

$136M

Previous: $185M-26.7%
Cash & Equivalents

$139M

Previous: $207M-32.9%
Total Assets

$3.96B

Previous: $4.01B-1.2%
Stock-Based Comp

$13.5M

Previous: $11M+22.6%

Revenue & EPS history

Woodward · Revenue · Quarterly

$538M

Q1 2021-25.4%vs Q1 2020
Beat estimate in 11 of 16 quarters(69%)
ActualEstimate

Revenue by segment

Woodward · $538M total across 2 segments · Q1 2021

  • Aerospace
    $322M-32.1%
  • Industrial
    $216M-12.2%

Forward guidance

The dynamic and volatile nature of the COVID-19 global pandemic has continued to cause uncertainty in many of our markets. Given this uncertainty, and the protracted nature of this crisis, we will continue to withhold financial guidance, although we are encouraged that ongoing stabilization will lead to recovery across the globe.

Tailwinds

  • Ongoing rollout of vaccines across the globe has begun.
  • Encouraged that ongoing stabilization will lead to recovery across the globe.

Headwinds

  • New viral variants and regional resurgences make forecasting the future of our business challenging in the near-term.
  • Uncertainty caused by the COVID-19 global pandemic.
  • Protracted nature of this crisis.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+1.3%

Avg return

Earnings day

+2.2%

Avg return

5 days after

+3.1%

Avg return

30 days after

58%

40 / 69 earnings

Positive

+18.5%

Q2 2023

Best reaction

-17.1%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2026-0.7%+1.3%-3.1%
Q1 2026+14.3%+18.7%+18.1%
Q4 2025+12.5%+14.9%+20.2%
Q3 2025-0.0%+0.4%-2.9%
Q2 2025+1.9%+6.9%+20.1%
Q1 2025-1.8%+3.9%-5.6%
Q4 2024+6.4%+2.4%-3.0%
Q3 2024-17.1%-16.8%-10.0%
Q2 2024+7.8%+12.1%+21.4%
Q1 2024+1.6%-2.2%+0.9%
Q4 2023-2.9%-2.4%+0.8%
Q3 2023+10.6%+5.5%+8.0%
Q2 2023+18.5%+13.4%+9.8%
Q1 2023-7.6%-6.2%-9.6%
Q4 2022-0.4%+1.2%-6.6%
Q3 2022-10.9%-9.0%-11.1%
Q2 2022-7.7%-5.6%-8.2%
Q1 2022+0.6%+1.3%+14.0%
Q4 2021-1.3%+0.4%-8.5%
Q3 2021-7.0%-6.5%+0.4%
Q2 2021+1.6%+3.9%+1.4%
Q1 2021+5.5%+4.2%+4.0%
Q4 2020+1.0%+6.7%+10.6%
Q3 2020+4.8%+12.0%+10.1%
Q2 2020-6.4%+5.7%+30.7%
Q1 2020-0.3%+2.2%-5.2%
Q4 2019+0.8%-2.4%+3.0%
Q3 2019-4.3%-1.5%-2.9%
Q2 2019+6.0%+9.4%+5.9%
Q1 2019+11.6%+14.6%+24.1%
Q4 2018+7.6%+3.4%-3.7%
Q3 2018+0.7%-5.3%-1.8%
Q2 2018-1.1%-2.5%+0.3%
Q1 2018-6.9%-5.7%-8.4%
Q4 2017+4.9%+1.7%-3.9%
Q3 2017+5.5%+2.5%-1.9%
Q2 2017-2.2%-1.2%-2.8%
Q1 2017+2.6%+3.6%+5.0%
Q4 2016+7.0%+5.9%+9.0%
Q3 2016-2.8%-2.7%+4.2%
Q2 2016+4.8%
Q1 2016-3.2%
Q4 2015+0.7%
Q3 2015-8.4%
Q2 2015+0.7%
Q1 2015+6.5%
Q4 2014-5.6%
Q3 2014+9.4%
Q2 2014+7.3%
Q1 2014-3.0%
Q4 2013+0.7%
Q3 2013-0.9%
Q2 2013+2.7%
Q1 2013-4.6%
Q4 2012+8.3%
Q3 2012-3.1%
Q2 2012+4.0%
Q1 2012+2.6%
Q4 2011-5.4%
Q3 2011-5.1%
Q2 2011-0.9%
Q1 2010-1.2%
Q1 2011+2.6%
Q4 2008+5.4%
Q2 2010+5.4%
Q4 2010+5.4%
Q3 2010+4.2%
Q4 2009+4.2%
Q3 2009+4.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro